Clinical Trial: CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours.

U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06986811) titled 'CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours.' on May 15.

Brief Summary: CEB-01-RLP01-CT trial is first-in-paediatrics, open label, exploratory, externally controlled clinical trial to evaluate safety, efficacy and pharmacokinetics of 7-ethyl-10-hydroxy-camptothecin (SN-38) formulated as a biocompatible polymeric nanofiber membrane (CEB-01) for treatment, in addition to standard of care, of paediatric patients from birth to less than 18 years of age with a localy resectable abdominal tumours including neuroblastoma soft-tissue sarcoma, Wilms, germ cell tumours and other tumours, in comparison to standard of care. ...